BioCentury
ARTICLE | Clinical News

Diepalrestat choline: Completed Phase IIb enrollment

May 23, 2016 7:00 AM UTC

BioNevia and NeuroMax completed enrollment of 400 patients in the double-blind, placebo-controlled, Russian Phase IIb NM-ARI-231 trial evaluating oral BNV-222 for 1 year. BioNevia and NeuroMax are dev...